BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dongiovanni P, Donati B, Fares R, Lombardi R, Mancina RM, Romeo S, Valenti L. PNPLA3 I148M polymorphism and progressive liver disease. World J Gastroenterol 2013; 19(41): 6969-6978 [PMID: 24222941 DOI: 10.3748/wjg.v19.i41.6969]
URL: https://www.wjgnet.com/1007-9327/full/v19/i41/6969.htm
Number Citing Articles
1
Eleonora Scorletti, Rotonya M. Carr. A new perspective on NAFLD: Focusing on lipid dropletsJournal of Hepatology 2022; 76(4): 934 doi: 10.1016/j.jhep.2021.11.009
2
Matthew Kappus, Manal Abdelmalek. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver TransplantationClinics in Liver Disease 2017; 21(2): 321 doi: 10.1016/j.cld.2016.12.006
3
Haiying Zhang, Li Xue, Lizhen Chen, Shunshun Jiang, Yongning Xin, Shiying Xuan. A Meta-Analysis of the Association Between the I148M Variant of Patatin-Like Phospholipase Domain Containing 3 Gene and the Presence of Chronic Hepatitis CHepatitis Monthly 2015; 15(11) doi: 10.5812/hepatmon.31987
4
Reem Al-Qarni, Muhammad Iqbal, Maram Al-Otaibi, Faisal Al-Saif, Assim A. Alfadda, Hisham Alkhalidi, Fahad Bamehriz, Mazen Hassanain. Validating candidate biomarkers for different stages of non-alcoholic fatty liver diseaseMedicine 2020; 99(36): e21463 doi: 10.1097/MD.0000000000021463
5
Martti Färkkilä, Hannu Kautiainen, Andrea Tenca, Kalle Jokelainen, Johanna Arola, Antonio De Vincentis. PNPLA3 allele frequency has no impact on biliary bile acid composition or disease course in patients with primary sclerosing cholangitisPLOS ONE 2022; 17(12): e0277084 doi: 10.1371/journal.pone.0277084
6
Maral Amangurbanova, Daniel Q. Huang, Rohit Loomba. Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLDAlimentary Pharmacology & Therapeutics 2023; 57(1): 37 doi: 10.1111/apt.17292
7
Samantha G. Tilson, Carola M. Morell, An‐Sofie Lenaerts, Seung Bum Park, Zongyi Hu, Benjamin Jenkins, Albert Koulman, T. Jake Liang, Ludovic Vallier. Modeling PNPLA3‐Associated NAFLD Using Human‐Induced Pluripotent Stem CellsHepatology 2021; 74(6): 2998 doi: 10.1002/hep.32063
8
Long Zhang, Wei You, Hanze Zhang, Rui Peng, Qin Zhu, Aihua Yao, Xiangcheng Li, Yebin Zhou, Xuehao Wang, Liyong Pu, Jindao Wu. PNPLA3 polymorphisms (rs738409) and non‐alcoholic fatty liver disease risk and related phenotypes: a meta‐analysisJournal of Gastroenterology and Hepatology 2015; 30(5): 821 doi: 10.1111/jgh.12889
9
Marica Meroni, Paola Dongiovanni, Miriam Longo, Fabrizia Carli, Guido Baselli, Raffaela Rametta, Serena Pelusi, Sara Badiali, Marco Maggioni, Melania Gaggini, Anna Ludovica Fracanzani, Stefano Romeo, Stefano Gatti, Nicholas O. Davidson, Amalia Gastaldelli, Luca Valenti. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytesEBioMedicine 2020; 52: 102658 doi: 10.1016/j.ebiom.2020.102658
10
Raffaela Rametta, Massimiliano Ruscica, Paola Dongiovanni, Chiara Macchi, Anna L. Fracanzani, Liliana Steffani, Silvia Fargion, Paolo Magni, Luca Valenti. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin‐A independently of insulin resistanceEuropean Journal of Clinical Investigation 2014; 44(7): 627 doi: 10.1111/eci.12280
11
Zongsheng Huang, Xianwen Guo, Guo Zhang, Liexin Liang, Bing Nong. Correlation between PNPLA3 rs738409 polymorphism and hepatocellular carcinoma: a meta-analysis of 10,330 subjectsThe International Journal of Biological Markers 2019; 34(2): 117 doi: 10.1177/1724600818812471
12
Tyler J Severson, Siddesh Besur, Herbert L Bonkovsky. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical reviewWorld Journal of Gastroenterology 2016; 22(29): 6742-6756 doi: 10.3748/wjg.v22.i29.6742
13
Piero Pingitore, Paola Dongiovanni, Benedetta Maria Motta, Marica Meroni, Saverio Massimo Lepore, Rosellina Margherita Mancina, Serena Pelusi, Cristina Russo, Andrea Caddeo, Giorgio Rossi, Tiziana Montalcini, Arturo Pujia, Olov Wiklund, Luca Valenti, Stefano Romeo. PNPLA3 overexpression results in reduction of proteins predisposing to fibrosisHuman Molecular Genetics 2016; : ddw341 doi: 10.1093/hmg/ddw341
14
Jian-Hua Shen, Yi-Ling Li, Dan Li, Ning-Ning Wang, Lei Jing, Yu-Hong Huang. The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysisJournal of Lipid Research 2015; 56(1): 167 doi: 10.1194/jlr.M048777
15
Anita Arslanow, Caroline S. Stokes, Susanne N. Weber, Frank Grünhage, Frank Lammert, Marcin Krawczyk. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP)Liver International 2016; 36(3): 418 doi: 10.1111/liv.12937
16
Luigi Boccuto, Ludovico Abenavoli, Lauren Cascio, Sujata Srikanth, Barbara DuPont, Andrew R. Mitz, Roger Curtis Rogers, Katy Phelan. Variability in Phelan‐McDermid syndrome: The impact of the PNPLA3 p.I148M polymorphismClinical Genetics 2018; 94(6): 590 doi: 10.1111/cge.13451
17
Stefano Romeo, Luca Valenti. Regulation of retinol‐binding protein 4 and retinol metabolism in fatty liver diseaseHepatology 2016; 64(5): 1414 doi: 10.1002/hep.28722
18
Roberta Fares, Salvatore Petta, Rosa Lombardi, Stefania Grimaudo, Paola Dongiovanni, Rosaria Pipitone, Raffaela Rametta, Anna Ludovica Fracanzani, Enrico Mozzi, Antonio Craxì, Silvia Fargion, Giorgio Sesti, Luca Valenti. The UCP2 ‐866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.Liver International 2015; 35(5): 1574 doi: 10.1111/liv.12707
19
Kentaro Oniki, Junji Saruwatari, Tomoko Izuka, Ayami Kajiwara, Kazunori Morita, Misaki Sakata, Koji Otake, Yasuhiro Ogata, Kazuko Nakagawa, Silvia C. Sookoian. Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight SubjectsPLOS ONE 2015; 10(7): e0132640 doi: 10.1371/journal.pone.0132640
20
Keyur Patel, Nicholas A. Shackel. Current status of fibrosis markersCurrent Opinion in Gastroenterology 2014; 30(3): 253 doi: 10.1097/MOG.0000000000000059
21
Giuseppina Umano, Mariangela Martino, Nicola Santoro. The Association between Pediatric NAFLD and Common Genetic VariantsChildren 2017; 4(6): 49 doi: 10.3390/children4060049
22
Lorne J. Hofseth, Ainsley Weston, Curtis C. Harris. Holland‐Frei Cancer Medicine2022; : 1 doi: 10.1002/9781119000822.hfcm023.pub2
23
Joseph A. Akambase, Jhon E. Prieto, Angelo Z. Mattos, Angelo A. Mattos, Enrique Carrera, Javier Díaz‐Ferrer, Patricia Gallardo, Andrea Curia, Esteban G. Ballerga, Cristiane V. Tovo, Domingo Balderramo, Jose D. Debes. Epidemiology and risk factors for histopathologic characteristics of non‐alcoholic fatty liver disease in South AmericaAlimentary Pharmacology & Therapeutics 2023; 58(5): 526 doi: 10.1111/apt.17615
24
Ines Volkert, Malin Fromme, Carolin Schneider, Lena Candels, Cecilia Lindhauer, Huan Su, Katrine Thorhauge, Monica Pons, Mohamed Ramadan Mohamed, Kai Markus Schneider, Pavel Strnad, Christian Trautwein. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progressionHepatology 2024; 79(4): 898 doi: 10.1097/HEP.0000000000000574
25
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinomaFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.984728
26
Alexander Yang, Emilio P. Mottillo. Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeuticsBiochemical Journal 2020; 477(5): 985 doi: 10.1042/BCJ20190468
27
R.B. Prussick, L. Miele. Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?British Journal of Dermatology 2018; 179(1): 16 doi: 10.1111/bjd.16239
28
Vittoria Manilla, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani. Type 2 Diabetes Mellitus and Liver Disease: Across the Gut–Liver Axis from Fibrosis to CancerNutrients 2023; 15(11): 2521 doi: 10.3390/nu15112521
29
Luca Valenti, Serena Pelusi. Non-Alcoholic Fatty Liver Disease2020; : 129 doi: 10.1007/978-3-319-95828-6_7
30
Konstantinos Arvanitakis, Theocharis Koufakis, Kalliopi Kotsa, Georgios Germanidis. The effects of sodium-glucose cotransporter 2 inhibitors on hepatocellular carcinoma: From molecular mechanisms to potential clinical implicationsPharmacological Research 2022; 181: 106261 doi: 10.1016/j.phrs.2022.106261
31
Somaya Albhaisi, Arun J. Sanyal. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic SteatohepatitisFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.665987
32
Guido Alessandro Baselli, Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Serena Pelusi, Marco Maggioni, Sara Badiali, Piero Pingitore, Samantha Maurotti, Tiziana Montalcini, Alice Emma Taliento, Daniele Prati, Giorgio Rossi, Anna Ludovica Fracanzani, Rosellina Margherita Mancina, Stefano Romeo, Luca Valenti. Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarkerGut 2020; 69(10): 1855 doi: 10.1136/gutjnl-2019-319226
33
Mohammed Eslam, Luca Valenti, Stefano Romeo. Genetics and epigenetics of NAFLD and NASH: Clinical impactJournal of Hepatology 2018; 68(2): 268 doi: 10.1016/j.jhep.2017.09.003
34
Nina L. Gluchowski, Michel Becuwe, Tobias C. Walther, Robert V. Farese. Lipid droplets and liver disease: from basic biology to clinical implicationsNature Reviews Gastroenterology & Hepatology 2017; 14(6): 343 doi: 10.1038/nrgastro.2017.32
35
Joseph Asemota, Olubunmi Oladunjoye, Atinuke Babalola, Ugonna Nwosu, Po-Hong S Liu, Adeolu O Oladunjoye, Nelsy Castro-Webb, Rebecca A Miksad. Comparison of Hepatocellular Carcinoma in Hispanics and Non-Hispanics PatientsCureus 2021;  doi: 10.7759/cureus.14884
36
Anna Viitasalo, Mustafa Atalay, Jussi Pihlajamäki, Jarmo Jääskeläinen, Ayhan Korkmaz, Dorota Kaminska, Virpi Lindi, Timo A. Lakka. The 148 M allele of the PNPLA3 is associated with plasma irisin levels in a population sample of Caucasian children: The PANIC StudyMetabolism 2015; 64(7): 793 doi: 10.1016/j.metabol.2015.01.010
37
Alessandro Mantovani, Stefano Ballestri, Amedeo Lonardo, Giovanni Targher. Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences 2016; 61(5): 1246 doi: 10.1007/s10620-016-4040-6
38
Patrick Borel, Charles Desmarchelier. Genetic Variations Associated with Vitamin A Status and Vitamin A BioavailabilityNutrients 2017; 9(3): 246 doi: 10.3390/nu9030246
39
Marina Kawaguchi-Suzuki, Kenneth Cusi, Fernando Bril, Yan Gong, Taimour Langaee, Reginald F. Frye. A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic SteatohepatitisFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00752
40
Ainura Amirkulova, Gulmira Derbissalina, Valeriy Benberin, Nasrulla Shanazarov, Gulshara Abildinova, Doskhan Kozhakhmet, Helena Katchman. Association between PNPLA3 and TM6SF2 gene polymorphisms and non-alcoholic fatty liver disease patients in KazakhstanElectronic Journal of General Medicine 2023; 20(6): em546 doi: 10.29333/ejgm/13718
41
Marcin Krawczyk, Raúl Jiménez-Agüero, José M. Alustiza, José I. Emparanza, María J. Perugorria, Luis Bujanda, Frank Lammert, Jesús M. Banales. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgerySurgery for Obesity and Related Diseases 2016; 12(10): 1838 doi: 10.1016/j.soard.2016.06.004
42
Rosa Lombardi, Salvatore Petta, Giuseppina Pisano, Paola Dongiovanni, Luca Rinaldi, Luigi Elio Adinolfi, Carlo Acierno, Luca Valenti, Roberta Boemi, Federica Spatola, Antonio Craxì, Silvia Fargion, Anna Ludovica Fracanzani. FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular DamageClinical Gastroenterology and Hepatology 2020; 18(2): 517 doi: 10.1016/j.cgh.2018.11.011
43
Yongqiang Ma, Guangshun Chen, Junfang Yi, Qiang Li, Zhi Tan, Wenling Fan, Xiaohua Luo, Zhiyong He, Zhongzhou Si, Jiequn Li. IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolismFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.895593
44
Cristiana Bianco, Elia Casirati, Francesco Malvestiti, Luca Valenti. Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targetsJHEP Reports 2021; 3(3): 100284 doi: 10.1016/j.jhepr.2021.100284
45
Olivier Govaere, Quentin M. Anstee. Encyclopedia of Cell Biology2023; : 610 doi: 10.1016/B978-0-12-821618-7.00265-0
46
Nathan L Meyers, Krystal A Fontaine, G Renuka Kumar, Melanie Ott. Entangled in a membranous web: ER and lipid droplet reorganization during hepatitis C virus infectionCurrent Opinion in Cell Biology 2016; 41: 117 doi: 10.1016/j.ceb.2016.05.003
47
Marica Meroni, Miriam Longo, Giada Tria, Paola Dongiovanni. Genetics Is of the Essence to Face NAFLDBiomedicines 2021; 9(10): 1359 doi: 10.3390/biomedicines9101359
48
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Parmjeet Randhawa, Eizaburo Sasatomi. Transplantation of the Liver2015; : 1112 doi: 10.1016/B978-1-4557-0268-8.00084-1
49
Alice Marmugi, Céline Lukowicz, Frederic Lasserre, Alexandra Montagner, Arnaud Polizzi, Simon Ducheix, Adeline Goron, Laurence Gamet-Payrastre, Sabine Gerbal-Chaloin, Jean Marc Pascussi, Marthe Moldes, Thierry Pineau, Hervé Guillou, Laila Mselli-Lakhal. Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent wayToxicology and Applied Pharmacology 2016; 303: 90 doi: 10.1016/j.taap.2016.05.006
50
Ludovico Abenavoli. Alcoholic Liver Disease: From Bench to BedsideReviews on Recent Clinical Trials 2019; 14(3): 158 doi: 10.2174/157488711403190718125454
51
Na Li, Xiaodan Li, Yifu Ding, Xiao Liu, Karin Diggle, Tatiana Kisseleva, David A. Brenner. SREBP Regulation of Lipid Metabolism in Liver Disease, and Therapeutic StrategiesBiomedicines 2023; 11(12): 3280 doi: 10.3390/biomedicines11123280
52
Maria A. Burza, Rocco Spagnuolo, Tiziana Montalcini, Patrizia Doldo, Arturo Pujia, Stefano Romeo. Effect of Excess Body Weight on the Genetic Susceptibility to CancerJournal of Clinical Gastroenterology 2014; 48(Supplement 1): S78 doi: 10.1097/MCG.0000000000000237
53
Hiroyasu Sakai, Yohei Shirakami, Masahito Shimizu. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsWorld Journal of Gastroenterology 2016; 22(1): 394-406 doi: 10.3748/wjg.v22.i1.394
54
Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Elena Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, Vasile Andrei Olteanu, Gabriela Ștefănescu. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver DiseaseMetabolites 2023; 13(11): 1115 doi: 10.3390/metabo13111115
55
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani. An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for PhysiciansBiomedicines 2023; 11(2): 586 doi: 10.3390/biomedicines11020586
56
Rosa Lombardi, Silvia Fargion, Anna Ludovica Fracanzani. Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic reviewDigestive and Liver Disease 2019; 51(9): 1214 doi: 10.1016/j.dld.2019.05.015
57
Azam Moslehi, Zeinab Hamidi-zad. Role of SREBPs in Liver Diseases: A Mini-reviewJournal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2017.00061
58
Omnia Aly, Hanan Hassan Zaki, Mohamed R. Herzalla, Ahmed Fathy, Nermin Raafat, Mohamed M. Hafez, Nadia M Hamdy. Gene polymorphisms of Patatin-like phospholipase domain containing 3 (PNPLA3), adiponectin, leptin in diabetic obese patientsPLOS ONE 2020; 15(6): e0234465 doi: 10.1371/journal.pone.0234465
59
Massimiliano Ruscica, Nicola Ferri, Chiara Macchi, Marica Meroni, Claudia Lanti, Chiara Ricci, Marco Maggioni, Anna Ludovica Fracanzani, Sara Badiali, Silvia Fargion, Paolo Magni, Luca Valenti, Paola Dongiovanni. Liver fat accumulation is associated with circulating PCSK9Annals of Medicine 2016; 48(5): 384 doi: 10.1080/07853890.2016.1188328
60
William S. Blaner. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disordersPharmacology & Therapeutics 2019; 197: 153 doi: 10.1016/j.pharmthera.2019.01.006
61
Anna Viitasalo, Jussi Pihlajamäki, Jussi Paananen, Mustafa Atalay, Virpi Lindi, Timo A Lakka. Associations of TM6SF2 167K allele with liver enzymes and lipid profile in children: the PANIC StudyPediatric Research 2016; 79(5): 684 doi: 10.1038/pr.2016.3
62
Anna Di Sessa, Giuseppina Rosaria Umano, Grazia Cirillo, Angela Del Prete, Roberta Iacomino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice. The Membrane‐bound O‐Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver DiseaseJournal of Pediatric Gastroenterology and Nutrition 2018; 67(1): 69 doi: 10.1097/MPG.0000000000001979
63
Edgar A. Villavicencio, Adriana Maldonado, Rebecca M. Crocker, Yue Guan, Chris Stallman, David O. Garcia. Communicating PNPLA3 genetic risk status for NAFLD among Mexican-origin menFrontiers in Public Health 2023; 10 doi: 10.3389/fpubh.2022.1090101
64
Sven M. Francque. Towards precision medicine in non-alcoholic fatty liver diseaseReviews in Endocrine and Metabolic Disorders 2023; 24(5): 885 doi: 10.1007/s11154-023-09820-6
65
Luca Valenti, Elisabetta Bugianesi, Utpal Pajvani, Giovanni Targher. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?Liver International 2016; 36(11): 1563 doi: 10.1111/liv.13185
66
Luigi Boccuto, Andrew Mitz, Ludovico Abenavoli, Sara M. Sarasua, William Bennett, Curtis Rogers, Barbara DuPont, Katy Phelan. Phenotypic Variability in Phelan–McDermid Syndrome and Its Putative Link to Environmental FactorsGenes 2022; 13(3): 528 doi: 10.3390/genes13030528
67
Xiao Yang, Frank J. Gonzalez, Min Huang, Huichang Bi. Nuclear receptors and non-alcoholic fatty liver disease: An updateLiver Research 2020; 4(2): 88 doi: 10.1016/j.livres.2020.03.001
68
Wenke Jonas, Annette Schürmann. Genetic and epigenetic factors determining NAFLD riskMolecular Metabolism 2021; 50: 101111 doi: 10.1016/j.molmet.2020.101111
69
S Pillai, S Duvvuru, P Bhatnagar, W Foster, M Farmen, S Shankar, C Harris, E Bastyr, B Hoogwerf, A Haupt. The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglisproThe Pharmacogenomics Journal 2018; 18(3): 487 doi: 10.1038/tpj.2017.45
70
Valerio Nobili, Anna Alisi, Luca Valenti, Luca Miele, Ariel E. Feldstein, Naim Alkhouri. NAFLD in children: new genes, new diagnostic modalities and new drugsNature Reviews Gastroenterology & Hepatology 2019; 16(9): 517 doi: 10.1038/s41575-019-0169-z
71
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, Rebecca H. Ritchie, Cheng Xue Qin. Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical TreatmentsFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.603926
72
Meng-Yuan Wu, Jian-Gao Fan. Gut microbiome and nonalcoholic fatty liver diseaseHepatobiliary & Pancreatic Diseases International 2023; 22(5): 444 doi: 10.1016/j.hbpd.2023.06.006
73
Stefano Romeo, Arun Sanyal, Luca Valenti. Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver DiseaseCell Metabolism 2020; 31(1): 35 doi: 10.1016/j.cmet.2019.12.002
74
Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni. Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCCInternational Journal of Molecular Sciences 2021; 22(8): 4173 doi: 10.3390/ijms22084173
75
Federico Salomone, Justyna Godos, Shira Zelber‐Sagi. Natural antioxidants for non‐alcoholic fatty liver disease: molecular targets and clinical perspectivesLiver International 2016; 36(1): 5 doi: 10.1111/liv.12975
76
Mark A. Febbraio, Saskia Reibe, Shabnam Shalapour, Geraldine J. Ooi, Matthew J. Watt, Michael Karin. Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?Cell Metabolism 2019; 29(1): 18 doi: 10.1016/j.cmet.2018.10.012
77
Hisamitsu Miyaaki, Kazuhiko Nakao. Significance of genetic polymorphisms in patients with nonalcoholic fatty liver diseaseClinical Journal of Gastroenterology 2017; 10(3): 201 doi: 10.1007/s12328-017-0732-5
78
Paola Dongiovanni, Stefano Romeo, Luca Valenti. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and SteatohepatitisBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/460190
79
Dilum Ekanayake, Clinton Roddick, Lawrie W. Powell. Recent advances in hemochromatosis: a 2015 updateHepatology International 2015; 9(2): 174 doi: 10.1007/s12072-015-9608-2
80
Ozlem Kutlu, Humeyra Nur Kaleli, Ebru Ozer. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular CarcinomaCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/8543763
81
Shuhua Yuan, Hongxia Liu, Ding Yuan, Jing Xu, Yunzhi Chen, Xiao Xu, Fen Xu, Hua Liang. PNPLA3 I148M mediates the regulatory effect of NF‐kB on inflammation in PA‐treated HepG2 cellsJournal of Cellular and Molecular Medicine 2020; 24(2): 1541 doi: 10.1111/jcmm.14839
82
Paola Dongiovanni, Jussi Pihlajamaki, Stefano Romeo, Luca Valenti. Reply to “Statin treatment for non-alcoholic steatohepatitis”Journal of Hepatology 2016; 64(1): 242 doi: 10.1016/j.jhep.2015.09.023
83
O. V. Smirnova, O. L. Moskalenko, E. V. Kasparov, I. E. Kasparova. Genetic predictors and pathophysiological features of non-alcoholic fat liver diseaseMeditsinskiy sovet = Medical Council 2021; (15): 78 doi: 10.21518/2079-701X-2021-15-78-87
84
Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver DiseaseInternational Journal of Environmental Research and Public Health 2019; 16(15): 2755 doi: 10.3390/ijerph16152755
85
Verena Wieser, Timon E. Adolph, Barbara Enrich, Patrizia Moser, Alexander R. Moschen, Herbert Tilg. Weight loss induced by bariatric surgery restores adipose tissue PNPLA3 expressionLiver International 2017; 37(2): 299 doi: 10.1111/liv.13222
86
Jose Altamirano, Eric S. Orman, Ramon Bataller. Yamada' s Textbook of Gastroenterology2015; : 2043 doi: 10.1002/9781118512074.ch103
87
Hisamitsu Miyaaki, Satoshi Miuma, Naota Taura, Hidetaka Shibata, Ryu Sasaki, Akihiko Soyama, Masaaki Hidaka, Mitsuhisa Takatsuki, Susumu Eguchi, Kazuhiko Nakao. Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver TransplantationTransplantation 2019; 103(1): 109 doi: 10.1097/TP.0000000000002319
88
Sofía Montemayor, Silvia García, Margalida Monserrat-Mesquida, Josep A. Tur, Cristina Bouzas. Dietary Patterns, Foods, and Nutrients to Ameliorate Non-Alcoholic Fatty Liver Disease: A Scoping ReviewNutrients 2023; 15(18): 3987 doi: 10.3390/nu15183987
89
Tsunehiro Ochi, Kensuke Munekage, Masafumi Ono, Takuma Higuchi, Masayuki Tsuda, Yoshihiro Hayashi, Nobuto Okamoto, Katsumi Toda, Shuji Sakamoto, Jude A. Oben, Toshiji Saibara. Patatin-like phospholipase domain-containing protein 3 is involved in hepatic fatty acid and triglyceride metabolism through X-box binding protein 1 and modulation of endoplasmic reticulum stress in miceHepatology Research 2016; 46(6): 584 doi: 10.1111/hepr.12587
90
Felice Cinque, Annalisa Cespiati, Rosa Lombardi, Andrea Costantino, Gabriele Maffi, Francesca Alletto, Lucia Colavolpe, Paolo Francione, Giovanna Oberti, Erika Fatta, Cristina Bertelli, Giordano Sigon, Paola Dongiovanni, Maurizio Vecchi, Silvia Fargion, Anna Ludovica Fracanzani. Interaction between Lifestyle Changes and PNPLA3 Genotype in NAFLD Patients during the COVID-19 LockdownNutrients 2022; 14(3): 556 doi: 10.3390/nu14030556
91
Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi, Harish Patel. Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature ReviewCancers 2024; 16(6): 1214 doi: 10.3390/cancers16061214
92
Emmi Suomela, Mervi Oikonen, Niina Pitkänen, Ari Ahola-Olli, Johanna Virtanen, Riitta Parkkola, Eero Jokinen, Tomi Laitinen, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Leena Taittonen, Päivi Tossavainen, Antti Jula, Britt-Marie Loo, Vera Mikkilä, Risto Telama, Jorma S.A. Viikari, Markus Juonala, Olli T. Raitakari. Childhood predictors of adult fatty liver. The Cardiovascular Risk in Young Finns StudyJournal of Hepatology 2016; 65(4): 784 doi: 10.1016/j.jhep.2016.05.020
93
Luigi Boccuto, Ludovico Abenavoli. The impact of genetic polymorphisms on liver diseases: entering the era of personalized medicineEuropean Journal of Gastroenterology & Hepatology 2017; 29(9): 1102 doi: 10.1097/MEG.0000000000000917
94
Simona Riccio, Rosa Melone, Caterina Vitulano, Pierfrancesco Guida, Ivan Maddaluno, Stefano Guarino, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomicsWorld Journal of Clinical Pediatrics 2022; 11(3): 221-238 doi: 10.5409/wjcp.v11.i3.221
95
Alessandra Caligiuri, Alessandra Gentilini, Fabio Marra. Molecular Pathogenesis of NASHInternational Journal of Molecular Sciences 2016; 17(9): 1575 doi: 10.3390/ijms17091575
96
Alexander J. Kovalic, Pratik Banerjee, Quynh T. Tran, Ashwani K. Singal, Sanjaya K. Satapathy. Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Experimental Hepatology 2018; 8(4): 390 doi: 10.1016/j.jceh.2018.04.001
97
Huan Su, Madhuri Haque, Svea Becker, Karolina Edlund, Julia Duda, Qingbi Wang, Johanna Reißing, Hanns‐Ulrich Marschall, Lena S. Candels, Mohamed Mohamed, Wilhelm Sjöland, Lijun Liao, Stephan A. Drexler, Till Strowig, Jörg Rahnenführer, Jan G. Hengstler, Maximilian Hatting, Christian Trautwein. Long‐term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animalsLiver International 2023; 43(8): 1699 doi: 10.1111/liv.15587
98
Eriks Smagris, Soumik BasuRay, John Li, Yongcheng Huang, Ka‐man V. Lai, Jesper Gromada, Jonathan C. Cohen, Helen H. Hobbs. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosisHepatology 2015; 61(1): 108 doi: 10.1002/hep.27242
99
Yuli Sun, Zhaofeng Tan, Zhenyuan Jiang, Min Li, Weiqin Wang, Yaoyao Huang, Jianguang Sun. Comparative efficacy and safety of traditional Chinese patent medicine for NAFLD in childhood or adolescenceMedicine 2021; 100(3): e24277 doi: 10.1097/MD.0000000000024277
100
Elias Björnson, Bani Mukhopadhyay, Anna Asplund, Nusa Pristovsek, Resat Cinar, Stefano Romeo, Mathias Uhlen, George Kunos, Jens Nielsen, Adil Mardinoglu. Stratification of Hepatocellular Carcinoma Patients Based on Acetate UtilizationCell Reports 2015; 13(9): 2014 doi: 10.1016/j.celrep.2015.10.045
101
P. Wainwright, E. Scorletti, C. D. Byrne. Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and PathogenesisCurrent Diabetes Reports 2017; 17(4) doi: 10.1007/s11892-017-0851-x
102
Francesca Lanzaro, Stefano Guarino, Elisabetta D'Addio, Alessandra Salvatori, Josè Alberto D'Anna, Pierluigi Marzuillo, Emanuele Miraglia del Giudice, Anna Di Sessa. Metabolic-associated fatty liver disease from childhood to adulthood: State of art and future directionsWorld Journal of Hepatology 2022; 14(6): 1087-1098 doi: 10.4254/wjh.v14.i6.1087
103
Pierre Bedossa, Keyur Patel. Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver DiseaseGastroenterology 2016; 150(8): 1811 doi: 10.1053/j.gastro.2016.03.008
104
Luigi Boccuto, Ludovico Abenavoli. Genetic and Epigenetic Profile of Patients With Alcoholic Liver DiseaseAnnals of Hepatology 2017; 16(4): 490 doi: 10.5604/01.3001.0010.0274
105
Stella De Nicola, Paola Dongiovanni, Alessio Aghemo, Cristina Cheroni, Roberta D'Ambrosio, Michele Pedrazzini, Francesco Marabita, Lorena Donnici, Marco Maggioni, Silvia Fargion, Massimo Colombo, Raffaele De Francesco, Luca Valenti, Matias A. Avila. Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis CPLoS ONE 2014; 9(8): e106022 doi: 10.1371/journal.pone.0106022
106
Ahmad Al-Mrabeh, Sviatlana V. Zhyzhneuskaya, Carl Peters, Alison C. Barnes, Shaden Melhem, Aaron Jesuthasan, Benjamin Aribisala, Kieren G. Hollingsworth, Georg Lietz, John C. Mathers, Naveed Sattar, Michael E.J. Lean, Roy Taylor. Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight LossCell Metabolism 2020; 31(2): 233 doi: 10.1016/j.cmet.2019.11.018
107
Claudia Maccali, Isabel V. A. Pereira, José Tadeu Stefano, Claudia P. Oliveira. Risk of Liver Cancer in MASLD: Role of Genetic Risk ScoresCurrent Hepatology Reports 2023; 22(4): 228 doi: 10.1007/s11901-023-00623-6
108
Ignacio Novo-Veleiro, Lucía Alvela-Suárez, Antonio-Javier Chamorro, Rogelio González-Sarmiento, Francisco-Javier Laso, Miguel Marcos. Alcoholic liver disease and hepatitis C virus infectionWorld Journal of Gastroenterology 2016; 22(4): 1411-1420 doi: 10.3748/wjg.v22.i4.1411
109
R. Liebe, F. Lammert, M. Krawczyk. Metabolism and Pathophysiology of Bariatric Surgery2017; : 389 doi: 10.1016/B978-0-12-804011-9.00051-0
110
Eric Trépo, Luca Valenti. Update on NAFLD genetics: From new variants to the clinicJournal of Hepatology 2020; 72(6): 1196 doi: 10.1016/j.jhep.2020.02.020
111
Ahmad Al-Mrabeh. Pathogenesis and remission of type 2 diabetes: what has the twin cycle hypothesis taught us?Cardiovascular Endocrinology & Metabolism 2020; 9(4): 132 doi: 10.1097/XCE.0000000000000201
112
Bubu A. Banini, Divya P. Kumar, Sophie Cazanave, Mulugeta Seneshaw, Faridoddin Mirshahi, Prasanna K. Santhekadur, Liangsu Wang, Hong Ping Guan, Abdul M. Oseini, Cristina Alonso, Pierre Bedossa, Srinivas V. Koduru, Hae‐Ki Min, Arun J. Sanyal. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of SteatohepatitisHepatology 2021; 73(4): 1290 doi: 10.1002/hep.31609
113
Alexander Yang, Emilio P. Mottillo, Ljiljana Mladenovic-Lucas, Li Zhou, James G. Granneman. Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytesNature Metabolism 2019; 1(5): 560 doi: 10.1038/s42255-019-0066-3
114
Benedetta Donati, Paola Dongiovanni, Stefano Romeo, Marica Meroni, Misti McCain, Luca Miele, Salvatore Petta, Silvia Maier, Chiara Rosso, Laura De Luca, Ester Vanni, Stefania Grimaudo, Renato Romagnoli, Fabio Colli, Flaminia Ferri, Rosellina Margherita Mancina, Paula Iruzubieta, Antonio Craxi, Anna Ludovica Fracanzani, Antonio Grieco, Stefano Ginanni Corradini, Alessio Aghemo, Massimo Colombo, Giorgio Soardo, Elisabetta Bugianesi, Helen Reeves, Quentin M. Anstee, Silvia Fargion, Luca Valenti. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individualsScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04991-0
115
Sunday Amos Onikanni, Bashir Lawal, Oluwafemi Shittu Bakare, Basiru Olaitan Ajiboye, Oluwafemi Adeleke Ojo, Abdullah Farasani, Saeed M Kabrah, Gaber El-Saber Batiha, Carlos Adam Conte-Junior. Cancer of the Liver and its Relationship with Diabetes mellitusTechnology in Cancer Research & Treatment 2022; 21: 153303382211197 doi: 10.1177/15330338221119743
116
Ana Cecilia Pontoriero, Julieta Trinks, María Laura Hulaniuk, Mariela Caputo, Lisandro Fortuny, Leandro Burgos Pratx, Analía Frías, Oscar Torres, Félix Nuñez, Adrián Gadano, Pablo Argibay, Daniel Corach, Diego Flichman. Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populationsBMC Genetics 2015; 16(1) doi: 10.1186/s12863-015-0255-3
117
Amal M.H. Mackawy, Mohamed E.H. Badawi, Ola Megahed. Patatin-like phospholipase domain containing-3 gene (PNPLA3) I148M polymorphism and liver damage in chronic hepatitis C Egyptian patientsEgyptian Journal of Medical Human Genetics 2015; 16(4): 333 doi: 10.1016/j.ejmhg.2015.06.001
118
Pierluigi Marzuillo, Anna Grandone, Laura Perrone, Emanuele Miraglia del Giudice. Understanding the pathophysiological mechanisms in the pediatric non-alcoholic fatty liver disease: The role of geneticsWorld Journal of Hepatology 2015; 7(11): 1439-1443 doi: 10.4254/wjh.v7.i11.1439
119
Rosa Lombardi, Alessandro Mantovani, Annalisa Cespiati, Paolo Francione, Gabriele Maffi, Elena Del Zanna, Claudio Maffeis, Antonio Colecchia, Nicola Passigato, Alberto Ferrarese, Caterina Daniela Cusumanu, Rosanna Villani, Emanuela Orsi, Valeria Grancini, Lorena Airaghi, Daniela Bignamini, Gaetano Serviddio, Giovanni Targher, Paola Dongiovanni, Silvia Fargion, Anna Ludovica Fracanzani. Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitorsDigestive and Liver Disease 2024; 56(4): 551 doi: 10.1016/j.dld.2023.09.023
120
Agostino Di Ciaula, Leonilde Bonfrate, Marcin Krawczyk, Gema Frühbeck, Piero Portincasa. Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver SteatosisInternational Journal of Molecular Sciences 2022; 23(5): 2636 doi: 10.3390/ijms23052636
121
Yanfang Zhang, Tongsheng Guo, Funing Yang, Yuanli Mao, Liubing Li, Chenxi Liu, Qiang Sun, Yongzhe Li, Jing Huang. Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese malesHepatology International 2018; 12(5): 429 doi: 10.1007/s12072-018-9889-3
122
Sean W.P. Koppe. Obesity and the liver: nonalcoholic fatty liver diseaseTranslational Research 2014; 164(4): 312 doi: 10.1016/j.trsl.2014.06.008
123
Susanne Schuster, Daniel Cabrera, Marco Arrese, Ariel E. Feldstein. Triggering and resolution of inflammation in NASHNature Reviews Gastroenterology & Hepatology 2018; 15(6): 349 doi: 10.1038/s41575-018-0009-6
124
Paloma Sangro, Manuel de la Torre Aláez, Bruno Sangro, Delia D’Avola. Metabolic dysfunction–associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatmentJournal of Physiology and Biochemistry 2023; 79(4): 869 doi: 10.1007/s13105-023-00954-4
125
Yan Zhao, Wenli Zhao, Jingchao Ma, Maeda Toshiyoshi, Ye Zhao. Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studiesMedicine 2023; 102(10): e33110 doi: 10.1097/MD.0000000000033110
126
Rosa Lombardi, Lucia Colavolpe, Francesca Alletto, Annalisa Cespiati, Erika Fatta, Cristina Bertelli, Felice Cinque, Giuseppina Pisano, Edoardo Pulixi, Paolo Francione, Gabriele Maffi, Federica Iuculano, Paola Dongiovanni, Marica Meroni, Larry Burdick, Daniela Bignamini, Marco Maggioni, Luca Valenti, Silvia Fargion, Anna Ludovica Fracanzani. Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decadesDigestive and Liver Disease 2024; 56(1): 144 doi: 10.1016/j.dld.2023.07.009
127
Rosellina Margherita Mancina, Rocco Spagnuolo, Marta Milano, Simona Brogneri, Attilio Morrone, Cristina Cosco, Veronica Lazzaro, Cristina Russo, Yvelise Ferro, Piero Pingitore, Arturo Pujia, Tiziana Montalcini, Patrizia Doldo, Pietro Garieri, Luca Piodi, Flavio Caprioli, Luca Valenti, Stefano Romeo. PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver EnzymesInflammatory Bowel Diseases 2016; 22(1): 134 doi: 10.1097/MIB.0000000000000569
128
Rosa Lombardi, Federica Iuculano, Giada Pallini, Silvia Fargion, Anna Ludovica Fracanzani. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular DiseaseInternational Journal of Molecular Sciences 2020; 21(22): 8761 doi: 10.3390/ijms21228761
129
Lorne J. Hofseth, Ainsley Weston, Curtis C. Harris. Holland‐Frei Cancer Medicine2017; : 1 doi: 10.1002/9781119000822.hfcm023
130
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto. Screening strategy for non-alcoholic fatty liver diseaseClinical and Molecular Hepatology 2023; 29(Suppl): S103 doi: 10.3350/cmh.2022.0336
131
Hyeyoung Kim, Kwang‐Woong Lee, Kyoungbun Lee, Sooin Seo, Min‐Young Park, Sung Woo Ahn, Suk Kyun Hong, Kyung Chul Yoon, Hyo‐Sin Kim, YoungRok Choi, Hae Won Lee, Nam‐Joon Yi, Kyung‐Suk Suh. Effect of PNPLA3 I148M polymorphism on histologically proven non‐alcoholic fatty liver disease in liver transplant recipientsHepatology Research 2018; 48(3) doi: 10.1111/hepr.12940
132
Luca Valenti, Stefano Romeo. Destined to develop NAFLD? The predictors of fatty liver from birth to adulthoodJournal of Hepatology 2016; 65(4): 668 doi: 10.1016/j.jhep.2016.06.010
133
Paola Dongiovanni, Erika Paolini, Alberto Corsini, Cesare R. Sirtori, Massimiliano Ruscica. Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approachesEuropean Journal of Clinical Investigation 2021; 51(7) doi: 10.1111/eci.13519
134
Amedeo Lonardo, Fabio Nascimbeni, Giovanni Targher, Mauro Bernardi, Ferruccio Bonino, Elisabetta Bugianesi, Alessandro Casini, Amalia Gastaldelli, Giulio Marchesini, Fabio Marra, Luca Miele, Filomena Morisco, Salvatore Petta, Fabio Piscaglia, Gianluca Svegliati-Baroni, Luca Valenti, Stefano Bellentani. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directionsDigestive and Liver Disease 2017; 49(5): 471 doi: 10.1016/j.dld.2017.01.147
135
Björn Carlsson, Daniel Lindén, Gabriella Brolén, Mathias Liljeblad, Mikael Bjursell, Stefano Romeo, Rohit Loomba. Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitisAlimentary Pharmacology & Therapeutics 2020; 51(12): 1305 doi: 10.1111/apt.15738
136
Sasanka Ramanadham, Tomader Ali, Jason W. Ashley, Robert N. Bone, William D. Hancock, Xiaoyong Lei. Calcium-independent phospholipases A2 and their roles in biological processes and diseasesJournal of Lipid Research 2015; 56(9): 1643 doi: 10.1194/jlr.R058701
137
Paola Dongiovanni, Luca Valenti. Genetics of nonalcoholic fatty liver diseaseMetabolism 2016; 65(8): 1026 doi: 10.1016/j.metabol.2015.08.018
138
Eleonora Scorletti, Annette L. West, Lokpal Bhatia, Samuel P. Hoile, Keith G. McCormick, Graham C. Burdge, Karen A. Lillycrop, Geraldine F. Clough, Philip C. Calder, Christopher D. Byrne. Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trialJournal of Hepatology 2015; 63(6): 1476 doi: 10.1016/j.jhep.2015.07.036
139
Rotonya M. Carr, Rexford S. Ahima. Pathophysiology of lipid droplet proteins in liver diseasesExperimental Cell Research 2016; 340(2): 187 doi: 10.1016/j.yexcr.2015.10.021
140
Cristina B. Guzman, Suman Duvvuru, Anthony Akkari, Pallav Bhatnagar, Chakib Battioui, Wendra Foster, Xiaotian Michelle Zhang, Sudha S. Shankar, Mark A. Deeg, Naga Chalasani, Thomas A. Hardy, Christof M. Kazda, Sreekumar G. Pillai. Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonistHepatology Communications 2018; 2(5): 561 doi: 10.1002/hep4.1171
141
Piero Pingitore, Stefano Romeo. The role of PNPLA3 in health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019; 1864(6): 900 doi: 10.1016/j.bbalip.2018.06.018
142
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Maria Vittoria Morone, Chiara Silvestri, Mauro Giordano, Teresa Salvatore, Ferdinando Carlo Sasso. Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative ReviewAntioxidants 2021; 10(2): 270 doi: 10.3390/antiox10020270
143
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiotaMetabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
144
Annalisa Crudele, Nadia Panera, Maria Rita Braghini, Clara Balsano, Anna Alisi. The pharmacological treatment of nonalcoholic fatty liver disease in childrenExpert Review of Clinical Pharmacology 2020; 13(11): 1219 doi: 10.1080/17512433.2020.1829468
145
Jun Luo, Zhongshan Lu, Zibiao Zhong, Meichen Pi, Yan Xiong, Ling Li, Ting Chen, Yiwen Chen, Cong-Yi Wang, Zhongzhong Liu, Qifa Ye. ALDH2 deficiency exacerbates MCD-diet induced MASLD by modulating bile acid metabolismFree Radical Biology and Medicine 2024; 212: 34 doi: 10.1016/j.freeradbiomed.2023.12.017
146
Onni Niemelä. Advances In Clinical ChemistryAdvances in Clinical Chemistry 2023; 116: 113 doi: 10.1016/bs.acc.2023.05.002
147
Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, Takashi Kadowaki. Role of Insulin Resistance in MAFLDInternational Journal of Molecular Sciences 2021; 22(8): 4156 doi: 10.3390/ijms22084156
148
Joost Boeckmans, Alexandra Gatzios, Jörn M. Schattenberg, Ger H. Koek, Robim M. Rodrigues, Tamara Vanhaecke. PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic reviewLiver International 2023; 43(5): 975 doi: 10.1111/liv.15533
149
Jérôme Boursier, Anna Mae Diehl. Patatin‐like phospholipase domain‐containing protein 3 and Liver Disease: Opportunities to Unravel Mechanisms Underlying Statistical AssociationsHepatology 2015; 61(1): 18 doi: 10.1002/hep.27445
150
Paola Dongiovanni, Raffaela Rametta, Marica Meroni, Luca Valenti. The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development – a potential therapeutic target?Expert Review of Gastroenterology & Hepatology 2016; 10(2): 229 doi: 10.1586/17474124.2016.1110018
151
Carmen Fierbinteanu-Braticevici, Crina Sinescu, Alexandru Moldoveanu, Ana Petrisor, Sorina Diaconu, Dragos Cretoiu, Bogdan Braticevici. Nonalcoholic fatty liver disease: one entity, multiple impacts on liver healthCell Biology and Toxicology 2017; 33(1): 5 doi: 10.1007/s10565-016-9361-x
152
Jincheng Wang, Tao Qin, Jinyu Sun, Shiwu Li, Lihua Cao, Xiaojie Lu. Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver diseaseFrontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1046497
153
Martijn R. Molenaar, Louis C. Penning, J. Bernd Helms. Playing Jekyll and Hyde—The Dual Role of Lipids in Fatty Liver DiseaseCells 2020; 9(10): 2244 doi: 10.3390/cells9102244
154
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormonesFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032361
155
Marco Arrese, Juan P. Arab, Francisco Barrera, Benedikt Kaufmann, Luca Valenti, Ariel E. Feldstein. Insights into Nonalcoholic Fatty-Liver Disease HeterogeneitySeminars in Liver Disease 2021; 41(04): 421 doi: 10.1055/s-0041-1730927
156
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems BiologyHepatology 2020; 72(1): 330 doi: 10.1002/hep.31229
157
Sandra Steensels, Jixuan Qiao, Baran A. Ersoy. Transcriptional Regulation in Non-Alcoholic Fatty Liver DiseaseMetabolites 2020; 10(7): 283 doi: 10.3390/metabo10070283
158
Dorothy A. Kieffer, Valentina Medici. Wilson disease: At the crossroads between genetics and epigenetics—A review of the evidenceLiver Research 2017; 1(2): 121 doi: 10.1016/j.livres.2017.08.003
159
Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni. Nutrition and Genetics in NAFLD: The Perfect BinomiumInternational Journal of Molecular Sciences 2020; 21(8): 2986 doi: 10.3390/ijms21082986
160
Marica Meroni, Miriam Longo, Paola Dongiovanni. Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver diseaseExploration of Medicine 2020; 1(4): 218 doi: 10.37349/emed.2020.00015
161
Sylwia Ziolkowska, Agata Binienda, Maciej Jabłkowski, Janusz Szemraj, Piotr Czarny. The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2021; 22(20): 11128 doi: 10.3390/ijms222011128
162
Luca Valenti, Paola Dongiovanni. Mutant PNPLA3 I148M protein as pharmacological target for liver diseaseHepatology 2017; 66(4): 1026 doi: 10.1002/hep.29298
163
Sven Francque, Vlad Ratziu. Future Treatment Options and Regimens for Nonalcoholic Fatty Liver DiseaseClinics in Liver Disease 2023; 27(2): 429 doi: 10.1016/j.cld.2023.01.010
164
Salvatore Petta, Luca Valenti, Elisabetta Bugianesi, Giovanni Targher, Stefano Bellentani, Ferruccio Bonino, Ele Ferrannini, Carmela Loguercio, Amedeo Lonardo, Fabio Marra, Marcello Mancini, Luca Miele, Valerio Nobili, Gianluca Svegliati Baroni, Federico Alessandro, Stefano Ballestri, Maurizia Rossana Brunetto, Barbara Coco, Antonio Grieco, Silvia Fargion, Loreta Kondili, Fabio Nascimbeni, Anna Prinster, Dante Romagnoli, Stefano Taddei, Ester Vanni, Stefano Vella. A “systems medicine” approach to the study of non-alcoholic fatty liver diseaseDigestive and Liver Disease 2016; 48(3): 333 doi: 10.1016/j.dld.2015.10.027
165
Haofei Hu, Changchun Cao, Yong Han, Yongcheng He. Triglyceride affects the association between estimated glomerular filtration rate and the onset of non-alcoholic fatty liver disease: A second analysis of a Chinese cohort studyFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.984241
166
Joseph L. Dempsey, George N. Ioannou, Rotonya M. Carr. Mechanisms of Lipid Droplet Accumulation in Steatotic Liver DiseasesSeminars in Liver Disease 2023; 43(04): 367 doi: 10.1055/a-2186-3557
167
Mirella Pastore, Alessandra Gentilini, Fabio Marra. Non-Alcoholic Fatty Liver Disease2020; : 97 doi: 10.1007/978-3-319-95828-6_6
168
Paola Dongiovanni, Salvatore Petta, Ville Mannisto, Rosellina Margherita Mancina, Rosaria Pipitone, Vesa Karja, Marco Maggioni, Pirjo Kakela, Olov Wiklund, Enrico Mozzi, Stefania Grimaudo, Dorota Kaminska, Raffaela Rametta, Antonio Craxi, Silvia Fargion, Valerio Nobili, Stefano Romeo, Jussi Pihlajamaki, Luca Valenti. Statin use and non-alcoholic steatohepatitis in at risk individualsJournal of Hepatology 2015; 63(3): 705 doi: 10.1016/j.jhep.2015.05.006
169
Rotonya M. Carr, Jason Correnti. Insulin resistance in clinical and experimental alcoholic liver diseaseAnnals of the New York Academy of Sciences 2015; 1353(1): 1 doi: 10.1111/nyas.12787
170
Kh. A. Kurtanov, L. A. Sydykova, N. I. Pavlova, N. P. Filippova, V. V. Dodokhov, G. A. Apsolikhova, N. A. Solov'eva, A. T. D'yakonova, L. M. Neustroeva, M. A. Varlamova, N. V. Borisova. Polymorphism of the adiponutrin gene (PNPLA3) in the indigenous inhabitants of the Republic of Sakha (Yakutia) with type 2 diabetes mellitusAlmanac of Clinical Medicine 2018; 46(3): 258 doi: 10.18786/2072-0505-2018-46-3-258-263
171
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesWorld Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
172
Paola Dongiovanni, Luca Valenti. A Nutrigenomic Approach to Non-Alcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2017; 18(7): 1534 doi: 10.3390/ijms18071534
173
Stephen A. Harrison. Nonalcoholic Fatty Liver Disease and Fibrosis Progression: The Good, the Bad, and the UnknownClinical Gastroenterology and Hepatology 2015; 13(4): 655 doi: 10.1016/j.cgh.2014.11.024
174
Nwe Ni Than, Philip N. Newsome. A concise review of non-alcoholic fatty liver diseaseAtherosclerosis 2015; 239(1): 192 doi: 10.1016/j.atherosclerosis.2015.01.001
175
Pierre Bedossa, David E. Kleiner. Alcoholic and Non-Alcoholic Fatty Liver Disease2016; : 223 doi: 10.1007/978-3-319-20538-0_12
176
Joost Willebrords, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle, Bert Van Den Bossche, Tereza Cristina Da Silva, Cláudia Pinto Marques Souza de Oliveira, Wellington Andraus, Venâncio Avancini Alves, Bruno Cogliati, Mathieu Vinken. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchProgress in Lipid Research 2015; 59: 106 doi: 10.1016/j.plipres.2015.05.002
177
Manoj Amrutkar, Urszula Chursa, Matthias Kern, Esther Nuñez‐Durán, Marcus Ståhlman, Silva Sütt, Jan Borén, Bengt R. Johansson, Hanns‐Ulrich Marschall, Matthias Blüher, Margit Mahlapuu. STK25 is a critical determinant in nonalcoholic steatohepatitisThe FASEB Journal 2016; 30(10): 3628 doi: 10.1096/fj.201600562R
178
A.‐J. Chamorro, J.‐L. Torres, J.‐A. Mirón‐Canelo, R. González‐Sarmiento, F.‐J. Laso, M. Marcos. Systematic review with meta‐analysis: the I148M variant of patatin‐like phospholipase domain‐containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosisAlimentary Pharmacology & Therapeutics 2014; 40(6): 571 doi: 10.1111/apt.12890
179
Michael Zimmer, Pradeep Bista, Ericka L. Benson, Diana Y. Lee, Feng Liu, Dominic Picarella, Rick B. Vega, Chi B. Vu, Maisy Yeager, Min Ding, Guosheng Liang, Jay D. Horton, Robert Kleemann, Teake Kooistra, Martine C. Morrison, Peter Y. Wielinga, Jill C. Milne, Michael R. Jirousek, Andrew J. Nichols. CAT‐2003: A novel sterol regulatory element‐binding protein inhibitor that reduces steatohepatitis, plasma lipids, and atherosclerosis in apolipoprotein E*3‐Leiden miceHepatology Communications 2017; 1(4): 311 doi: 10.1002/hep4.1042
180
Alison Mondul, Rosellina M Mancina, Andrea Merlo, Paola Dongiovanni, Raffaela Rametta, Tiziana Montalcini, Luca Valenti, Demetrius Albanes, Stefano Romeo. PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity ,The Journal of Nutrition 2015; 145(8): 1687 doi: 10.3945/jn.115.210633
181
Ivica Grgurevic, Tonci Bozin, Mislav Mikus, Michal Kukla, James O’Beirne. Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic ApproachCancers 2021; 13(22): 5844 doi: 10.3390/cancers13225844
182
Carolyn Vespoli, Anoop Mohamed Iqbal, Mohammad Nasser Kabbany, Kadakkal Radhakrishnan. Metabolic-Associated Fatty Liver Disease in Childhood and AdolescenceEndocrinology and Metabolism Clinics of North America 2023; 52(3): 417 doi: 10.1016/j.ecl.2023.02.001